ERGOMED Group Sites
Global, full-service CRO specializing in oncology and rare disease
Solutions for clinical safety and post-marketing pharmacovigilance
QA oversight, risk visibility, and confidence in global compliance
Get in Touch
ERGOMED Group improves pharmaceutical-led care by making clinical research more productive, reducing regulatory risk, and protecting both patient safety and asset value. Biopharmaceutical firms trust our brands for global reach, deep expertise, and scale to support their goals from product development through commercialization.
Our three brands – Ergomed CRO, PrimeVigilance, and ADAMAS Consulting – offer a highly engaged workforce that delivers a market-leading client experience.
Ergomed begins
Clinical investigator Dr. Miroslav Reljanović founds Ergomed in Zagreb, Croatia.
First co-development deal
Dr. Reljanovic successfully introduces an innovative co-development business model to support clinical programs across Europe.
PrimeVigilance launches
Well-known international drug safety expert, Elliot Brown, and Dr. Reljanović form PrimeVigilance, which aims to be a leading specialist in pharmacovigilance services.
Ergomed IPO
Ergomed is successfully added to the AIM market of the London Stock Exchange and trades under the symbol ERGO.
Aquisiton of Sound Opinion
Ergomed acquires Sound Opinion, a medical information service company, to bolster the PrimeVigilance offering.
Acquisition of Haemostatix
Ergomed acquires Nottingham-based Haemostatix to access its proprietary technology and pipeline products PeproStat™ and ReadyFlow™.
Acquisition of O+P, GASD
German-based CRO company, O+P, and GASD, a biostatistics company, is acquired to bolster Ergomed’s full-service offering.
Acquisition of PharmInvent
Ergomed acquires leading pharmacovigilance and regulatory services business, PharmInvent.
Acquisition of PSR
Ergomed acquires PSR Group BV, a specialist orphan drug CRO, to further enhance its expertise in rare diseases.
Acquisition of Ashfield PV
Ashfield Pharmacovigilance, a US-based specialist pharmacovigilance services provider, is acquired to increase our support for US clients.
Acquisition of MedSource
Ergomed acquires MedSource, an award-winning, oncology-focused US-based CRO to further grow our footprint in the US.
Integration of ADAMAS
Ergomed integrates ADAMAS, a leading global regulatory compliance provider.
Permira completes acquisition of Ergomed
Ergomed strongly positioned for future growth in new partnership with Permira
Acquisition of Panacea
Ergomed acquired Panacea, a company based in the Isle of Man, British Isles.
Integration of Prudentia Group
PrimeVigilance and Prudentia Group unite to deliver end-to-end pharmacovigilance and safety database solutions.
Acquisition of PhV Latam
Acquisition of PhV LATAM to strengthen local pharmacovigilance expertise and regulatory presence across Latin America.
Acquisition of Bloom Agents
Acquisition of Bloom Agents to expand pharmacovigilance and regulatory capabilities across the Asia-Pacific region.
PrimeVigilance
Solutions for clinical safety and post-marketing pharmacovigilance.
ADAMAS Consulting
QA oversight, risk visibility, and confidence in global compliance.
This site uses cookies to personalize and customize your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.
